I think those things contribute to the problem. We have had a lot of experience with opioid agonist treatment over a very long time. It has been accepted that this is a chronic recurrent disease and that people typically go through stages of remission and relapse. That process has continued, but as people relapse they're now being faced with a far more toxic illicit drug supply. It's far more dangerous to relapse off opioid agonist treatment nowadays, and so we need more options to keep people safe.
Treatment is one part of a continuum of services that we need. I think we need to adjust our expectations and adjust our knowledge, based on the introduction of new contaminants into the drug supply, which is still happening. The ground is still shifting beneath our feet here. We're trying hard to keep up. It's painful to watch our outcomes continue to deteriorate and it's painful to hear from physicians who are trying their best to keep their patients alive. It's difficult.